DataMeds AI unit Helomics wins Humana Medicaid coverage for ChemoFx gynecologic cancer assay
Bitget2026/10/12 10:00- DataMeds AI’s Helomics unit secured Medicaid coverage under Humana policy for its ChemoFx chemoresponse assay in gynecologic cancers.
- Coverage took effect July 22, 2026 under Humana policy HUM-SC-2240-003, billed under CPT codes 81535 and 81536.
- Eligibility centers on select clinical scenarios, including recurrence or treatment-refractory disease, supporting potential volume growth for Helomics’ CLIA lab.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs traders warn of an "invisible bear market": S&P 500 is only 3% away from its all-time high, but 60% of its constituent stocks have entered bear market territory.
The S&P 500 Index is only about 3% away from its latest record high, but 60% of the constituent stocks in this benchmark index are deeply entrenched in bear market territory.
Iljin Display Faces Delisting Review as Improvement Period Ends
After five months of sell-offs, is there finally a turning point? With expectations of a Democratic victory, funds bet on a rebound in clean energy stocks and options trading volume surges.
As prediction markets bet that Democrats will achieve a significant victory in Tuesday’s US midterm elections, traders are directing funds toward a group of stocks typically seen as beneficiaries under a left-leaning government, including clean energy shares.
Crypto prices
More
